Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Aclaris Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor for the Treatment of Moderate to Severe Atopic Dermatitis
-
AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease
-
Edison Issues Report on SynBiotic (SBX)
-
Industry leaders to speak at Wood Mackenzie’s Carbon Capture, Utilization and Storage Conference 2024
-
Nebraska Medicine and Palantir Announce Pioneering Partnership to Use AI Technology to Advance Healthcare
-
Talos Energy Publishes Annual Sustainability Report
-
Xometry Europe Gives Enterprise Customers More Options To Quote And Manage Complex, High-Volume Projects
-
Aluf Holdings, Inc. Welcomes Dr. Matthew Leftwich CTO and COO to the Board and Announces Strategic Acquisition of Nanomatronix, LLC
-
Ryder Leaders Honored with 2024 Women in Supply Chain Award
-
VENTURE GLOBAL EXPANDS EUROPEAN REGASIFICATION CAPACITY
-
Timken Named One of Fast Company's Best Workplaces for Innovators in Manufacturing
-
Zoomcar Announces First Annual Stockholder Meeting 2024
-
Mallinckrodt Announces Publication of Human Factors Studies and Arthritis Foundation Ease of Use® Certification of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™
-
Albion Venture Capital Trust PLC: Interim Management Statement
-
Trane Technologies Recognized by TIME, PEOPLE and Fortune for Workforce, Culture and Commitment to Sustainability
-
Alliance Trust PLC - Net Asset Value
-
Ferguson Reports Fourth Quarter and Year End Results; Issues FY2025 Guidance
-
Adbry® (tralokinumab-ldrm) Autoinjector Now Available for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis (AD) in the U.S.
-
MediPharm Labs Announces $2.1M Debt Repayment
-
Greenstein & Milbauer is Making a Difference for Injured Construction Workers
-
Canada Nickel's NetZero Metals Subsidiary Announces Formation of Advisory Board of Global Metallurgical Leaders and Management Appointment
-
‘MADE in NJ’ Manufacturing Day 2024 Finalists Announced: Celebrating Excellence in Innovation and Leadership in New Jersey’s Manufacturing Industry
-
BioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024
-
Electra Vehicles to Showcase Cutting-Edge AI-Powered Battery Innovation at The Battery Show 2024 and CES 2025
-
From the Tax Law Offices of David W. Klasing - Film Producer and Accountant Indicted for Multi-Million Dollar Offshore Tax Fraud Scheme
-
SLB launches AI-powered Lumi platform
-
Cohere Beauty Marks Anniversary with Remarkable Post-Restructure Growth
-
BlackDice and Bin Omran Announce Partnership
-
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas Step-Out Drills 7 Metres @ 9.1 g/t gold & 706 ppm Cobalt
-
Zedge Unveils Significant Enhancements to its Gen AI Creation Tool for iOS
-
Heliostar Commences 5,000 Metre Resource Expansion Drill Program at Ana Paula High Grade Gold Project, Mexico and Issues Incentive Grant
-
Westwater Resources Announces Off-Take Agreement for Sale of 100% of Fines Graphite Production from its Kellyton Plant
-
Nura Bio Closes Series A Financing with $68 Million in New Funds, Bringing Total Raised to $140+ Million
-
Agellus Capital Completes Investment in BlackPoint IT Services
-
SITE Centers Provides Third Quarter 2024 Transaction and Spin-Off Update
-
Henry Schein to Serve as Exclusive Distributor of Curodont to Dental Service Organizations
-
SITE Centers Announces Board of Directors and CFO Appointments
-
Recruit Rooster Wins Gold in the 2024 MUSE Creative Awards for Video Production
-
Sverica Capital Management Announces Growth Investment in FOUR Inc.
-
VIAVI Introduces Innovative Benchtop Microscopy Solution at ECOC 2024
-
Ducommun to Participate in RBC Global Industrials Conference
-
ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.
-
Cevira (APL-1702): Photocure Partner Asieris Unveils Efficacy Data of Non-Surgical Treatment of Cervical HSIL at the 2024 PDT&PD Conference
-
Akamai Finds Geopolitical Tensions Driving Surge in DDoS Attacks on Financial Institutions
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
CHEP Automotive releases its fifth supply chain trend report
-
Dimensional Fund Advisors Ltd. : Form 8.3 - VIRGIN MONEY UK PLC - Ordinary Shares
-
Ascletis Enters the Obesity Drug Space with Announcement of Two Ongoing U.S. Phase I Clinical Trials Utilizing Its Small Molecule GLP-1R Agonist ASC30 for Both Once-Monthly Subcutaneous Injection and
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SEGRO plc - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - RIGHTMOVE PLC - Ordinary Shares
